Patents Assigned to Nanjing Norman Biological Technology Co., Ltd.
  • Monoclonal antibody of human-derived procalcitonin, and preparation method and application thereof
    Patent number: 10882900
    Abstract: The present invention provides a monoclonal antibody that specifically binds to human-derived procalcitonin and application thereof. The present invention also provides a hybridoma cell line secreting the monoclonal antibody and having an accession number of CGMCC No. 10417, and a method for preparing an antibody against procalcitonin by using a procalcitonin mutant antigen as the immunogen.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: January 5, 2021
    Assignee: Nanjing Norman Biological Technology Co., Ltd.
    Inventors: Sen Ye, Shizhao He